Monday, October 10, 2016

Paremyd


Paremyd is a brand name of hydroxyamphetamine/tropicamide ophthalmic, approved by the FDA in the following formulation(s):


PAREMYD (hydroxyamphetamine hydrobromide; tropicamide - solution/drops; ophthalmic)



  • Manufacturer: AKORN

    Approval date: January 30, 1992

    Strength(s): 1%;0.25% [RLD]

Has a generic version of Paremyd been approved?


No. There is currently no therapeutically equivalent version of Paremyd available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Paremyd. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Paremyd.

See also...

  • Paremyd Consumer Information (Wolters Kluwer)
  • Paremyd Ophthalmic Advanced Consumer Information (Micromedex)
  • Hydroxyamphetamine/Tropicamide Consumer Information (Wolters Kluwer)
  • Hydroxyamphetamine and tropicamide Ophthalmic Advanced Consumer Information (Micromedex)

No comments:

Post a Comment